The current study further found that 18F-PSMA-1007 PET/CT radiomic features are promising markers for the noninvasive discrimination of low-intermediate and high pathological risk, and different PSA serum values (<20 vs. ≥20 ng/mL) in patients with PCa. This evidence concerns the gene KLK3 and posterior cortical atrophy.